Annual Current Liabilities
$14.60 M
+$12.35 M+548.07%
December 31, 2023
Summary
- As of February 7, 2025, EPRX annual total current liabilities is $14.60 million, with the most recent change of +$12.35 million (+548.07%) on December 31, 2023.
- During the last 3 years, EPRX annual current liabilities has fallen by -$3.07 million (-17.39%).
- EPRX annual current liabilities is now -17.39% below its all-time high of $17.68 million, reached on December 1, 2020.
Performance
EPRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.37 M
-$9.23 M-79.55%
September 1, 2024
Summary
- As of February 7, 2025, EPRX quarterly total current liabilities is $2.37 million, with the most recent change of -$9.23 million (-79.55%) on September 1, 2024.
- Over the past year, EPRX quarterly current liabilities has dropped by -$9.23 million (-79.55%).
- EPRX quarterly current liabilities is now -87.75% below its all-time high of $19.37 million, reached on December 31, 2023.
Performance
EPRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
EPRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +548.1% | -79.5% |
| 3 y3 years | -17.4% | +33.4% |
| 5 y5 years | +38.7% | - |
EPRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +721.1% | -87.8% | +134.7% |
| 5 y | 5-year | -17.4% | +721.1% | -87.8% | +260.4% |
| alltime | all time | -17.4% | +2413.2% | -87.8% | +260.4% |
Eupraxia Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.37 M(-79.6%) |
| Jun 2024 | - | $11.60 M(-37.4%) |
| Mar 2024 | - | $18.53 M(-4.4%) |
| Dec 2023 | $14.60 M(+548.1%) | $19.37 M(+36.6%) |
| Sep 2023 | - | $14.18 M(+28.7%) |
| Jun 2023 | - | $11.02 M(+260.2%) |
| Dec 2022 | $2.25 M | - |
| Dec 2022 | - | $3.06 M(+85.6%) |
| Sep 2022 | - | $1.65 M(-40.9%) |
| Jun 2022 | - | $2.79 M(+175.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.01 M(-43.2%) |
| Dec 2021 | $1.78 M(-89.9%) | $1.78 M(-20.3%) |
| Sep 2021 | - | $2.23 M(+238.8%) |
| Jun 2021 | - | $658.40 K(-89.1%) |
| Mar 2021 | - | $6.07 M(-65.7%) |
| Dec 2020 | $17.68 M(+11.7%) | $17.68 M(+7.1%) |
| Sep 2020 | - | $16.51 M(+4.4%) |
| Dec 2019 | $15.82 M(+50.2%) | $15.82 M |
| Dec 2018 | $10.53 M(+1712.4%) | - |
| Dec 2017 | $581.10 K | - |
FAQ
- What is Eupraxia Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual current liabilities year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly current liabilities year-on-year change?
What is Eupraxia Pharmaceuticals annual total current liabilities?
The current annual current liabilities of EPRX is $14.60 M
What is the all time high annual current liabilities for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual total current liabilities is $17.68 M
What is Eupraxia Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, EPRX annual total current liabilities has changed by +$12.35 M (+548.07%)
What is Eupraxia Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of EPRX is $2.37 M
What is the all time high quarterly current liabilities for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly total current liabilities is $19.37 M
What is Eupraxia Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, EPRX quarterly total current liabilities has changed by -$9.23 M (-79.55%)